Search

everythinglearnresearchcommunity

for

Search:↓

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Testosterone replacement can help menopausal women with various symptoms, but should be used carefully and is not yet officially licensed in the UK for women.

Menstrual abnormalities in PCOS women may not greatly affect their metabolic and hormonal profile.

Ovarian volume is significantly related to higher levels of certain hormones in Korean women with PCOS.

Clinical signs of hyperandrogenism are related to female pattern hair loss severity, but biochemical markers are not.

Pediatric androgenetic alopecia is linked to obesity, family history, hormonal imbalances, and requires personalized treatment including managing comorbidities.

Using stem cells from hair follicles to treat female hair loss is safe and effective after six months.

Lipid Accumulation Product and Free Androgens Index are effective for assessing fatty liver disease risk in women with Polycystic Ovary Syndrome.

Most adult females with acne do not have hormonal imbalances, but some show signs of excess male hormones.

Certain medications can reduce mortality risk in COPD patients, but others can increase risks of cardiovascular issues, postoperative delirium, and other adverse effects.

Nafarelin may effectively treat excessive hair growth in women by reducing certain hormone levels.

The study concluded that a higher waist-hip ratio significantly increases the risk of metabolic syndrome in women with PCOS.

PCOS is often linked with menstrual issues, hormonal imbalances, and a higher risk of heart disease and diabetes.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

Injecting 2 ml of TEEV every 4 weeks is better because it has the same benefits but fewer side effects.

The guide recommends specific methods for diagnosing PCOS and various treatments for its symptoms, while considering the health impacts on adolescents.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Women with hyperandrogenism have higher androgen levels and lower SHBG, which may contribute to conditions like excessive hair growth and early puberty.

Spironolactone improved symptoms in women with hormonal imbalances and had few side effects.

Monitoring for adverse effects in clinical treatments is crucial.

Many women with polycystic ovarian disease show symptoms like excessive hair growth, acne, hair loss, and have high levels of certain hormones.

The new rodent model successfully mimics non-lean human PCOS symptoms.

Androgens are important for female fertility and could help in IVF treatment, but also play a role in causing PCOS.

A new treatment for hair loss was tested and most participants saw their hair loss stop within 2-8 weeks, with up to 50% more hair after 4 months, and no side effects.

Telogen effluvium is a type of hair loss in women caused by many factors, and iron and thyroid tests are recommended for diagnosis.

Bilateral Orchiectomy effectively reduces the need for anti-androgen medication in most transgender females.

Thyroid function affects skin health, with a complex interaction between the two.

Hormone therapies like birth control pills and spironolactone are safe and effective for treating women's adult acne.

The combination therapy reduced hirsutism in women with PCOD and was well-tolerated.